AcuCort AB, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to Finansinspektionen. From 18 October 2025 to 18 October 2026, the disclosure feed for AcuCort AB logged 4 filings by 4 insiders.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
With 4 filings in twelve months, the company is quieter than the median of 8 filings across the 880 companies we follow on the same exchange.
Insider buying of AcuCort AB has been absent for the past year. Typically, a trade is published a median of 1 day after it takes place. Under the Market Abuse Regulation, managers have three business days to notify their trades.
In the same sector, recent insider purchases at Anixa Biosciences Inc and Vivos Inc also feature in our signals. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
FY ended December 2025 · cache
5 of 5 declarations
AcuCort AB is a company focused on developing treatments for inflammatory diseases. It is listed on the Stockholm Stock Exchange (XSTO).
Purchases our model currently ranks for the recommendations list.
All recommendations